Kevin M. Felsenstein

Author

Also Known As

Connie New, K M Felsenstein, K. Felsenstein, K. M. Felsenstein, K.M. Felsenstein, KEVIN M. FELSENSTEIN, Kevin Felsenstein, Kevin M Felsenstein, Kevin M. Felsenstein

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)University of Florida University of California San Diego Bristol-Myers Squibb (Germany)Harvard University

About

Kevin M. Felsenstein is an author at Bristol-Myers Squibb (United States) specializing in medicine, natural sciences, and alzheimer's disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	23	1.7K
2	Natural Sciences	11	12	425
3	Biochemistry	9	9	336
4	Social Sciences	5	5	891
5	Engineering	1	1	81

Kevin M. Felsenstein

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Alzheimer–associated presenilins 1 and 2 : Neuronal expression in brain and localization to intracellular membranes in mammalian cells Dora M. Kovacs, Hillary J. Fausett, Keith J. Page, Nature Medicine Synaptic PlasticityNeurodegenerative DiseasesAlzheimer's DiseaseMolecular NeuroscienceNeuronal Expression	1996	552
Expression and analysis of presenilin 1 in a human neuronal system: localization in cell bodies and dendrites. David G. Cook, Jaemyoung Sung, Todd E. Golde, Proceedings of the National Academy of Sciences Nt2n NeuronsCellular NeurobiologyCellular PhysiologyChromosome 14Social Sciences	1996	202
Dynamics of β-Amyloid Reductions in Brain, Cerebrospinal Fluid, and Plasma of β-Amyloid Precursor Protein Transgenic Mice Treated with a γ-Secretase Inhibitor Donna M. Barten, Valerie Guss, Jason A. Corsa, Journal of Pharmacology and Experimental Therapeutics	2005	159
Expression of the gag-pol fusion protein of Moloney murine leukemia virus without gag protein does not induce virion formation or proteolytic processing Kevin M. Felsenstein, Stephen P. Goff Journal of Virology Viral ReplicationMolecular BiologyMolecular GeneticsViral Structural ProteinVirus Structure	1988	126
Non-amyloidogenic cleavage of the beta-amyloid precursor protein by an integral membrane metalloendopeptidase. Susan B. Roberts, James A. Ripellino, Kim M. Ingalls, Journal of Biological Chemistry Protein FunctionAlzheimer's DiseaseBiochemistryProtein FoldingNatural Sciences	1994	110
Reductions in β-amyloid concentrations in vivo by the γ-secretase inhibitors BMS-289948 and BMS-299897 Jeffery J. Anderson, Greg Holtz, Patricia Baskin, Biochemical Pharmacology Molecular PharmacologyNeurodegenerative DiseasesAlzheimer's Diseaseγ-Secretase Inhibitors Bms-289948Biochemistry	2005	93
Altered cleavage and secretion of a recombinant β–APP bearing the Swedish familial Alzheimer's disease mutation Kevin M. Felsenstein, Lisa Hunihan, Susan B. Roberts Nature Genetics Neurodegenerative DiseasesAlzheimer's DiseaseMolecular NeuroscienceGeneticsSwedish Familial Alzheimer	1994	90
Inhibitors of Aβ production: solid-phase synthesis and SAR of α-hydroxycarbonyl derivatives Owen B. Wallace, David W. Smith, Milind Deshpande, Bioorganic & Medicinal Chemistry Letters Aβ ProductionMedicinal ChemistryDerivativesSolid-phase SynthesisEngineering	2003	81
Modulation of γ-secretase by EVP-0015962 reduces amyloid deposition and behavioral deficits in Tg2576 mice Kathryn E. Rogers, Kevin M. Felsenstein, Lori Hrdlicka, Molecular Neurodegeneration	2012	72
The stress response neuropeptide <scp>CRF</scp> increases amyloid‐β production by regulating γ‐secretase activity Hyo‐Jin Park, Yong Ran, Joo In Jung, The EMBO Journal Neurodegenerative DiseasesMolecular NeuroscienceAlzheimer's DiseaseAmyloid‐β ProductionMedicine	2015	55

Page 1